Periendoscopic management of antiplatelet therapy: Prospective evaluation of adherence to guidelines
| Autor: | Lidia Argüello, Noelia Alonso, Belén Navarro, Marta Ponce, Carla Satorres, Marco Bustamante-Balén, Francia Carolina Diaz, Gema Plumé, Vicente Pons-Beltrán |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Adult
Male medicine.medical_specialty Guidelines Endoscopy Gastrointestinal Prospective evaluation Internal medicine medicine Humans Prospective Studies Aged Gastrointestinal endoscopy Aged 80 and over Thrombotic risk Aspirin Hepatology medicine.diagnostic_test business.industry Contraindications Drug Gastroenterology Primary care physician Endoscopy Colonoscopy Middle Aged Clopidogrel Upper GI endoscopy Adequacy Cross-Sectional Studies Oral antiplatelet therapy Practice Guidelines as Topic Female Guideline Adherence Gastrointestinal Hemorrhage business Platelet Aggregation Inhibitors medicine.drug |
| Zdroj: | GASTROENTEROLOGIA Y HEPATOLOGIA r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe instname |
| ISSN: | 0210-5705 |
| Popis: | Introduccion: Adherence to guidelines on the periendoscopic management of antiplatelet therapy (APT) has not been analyzed in detail. Our aim was to assess adherence to guidelines in patients referred to our Endoscopy Unit on a case-by-case basis, describing in detail the detected deviations and identifying areas of improvement. Patients and methods: Cross-sectional study of outpatients consecutively scheduled for an unsedated upper or lower gastrointestinal endoscopy between January and June 2015. Patients on anticoagulant therapy were excluded. Results: 675 patients were evaluated, including 91 (13.5%) patients on APT [upper GI endoscopy 25 (27.5%), lower GI endoscopy 66 (72.5%)] Contrary to the clinical guidelines, aspirin was discontinued in 25 of the 77 patients previously prescribed the drug (32.5%) but this modification was patient's own decision in 11 cases. Most of the apparent deviations in the management of clopidogrel and dual antiplatelet therapy (DAPT) were not true non-adherence cases. The Primary Care physician modified an APT prescribed by another physician in 8 of 9 cases (88.9%), always in cases with aspirin. No relationship was found between the endoscopic procedure's predicted risk of bleeding or the patient's thrombotic risk and modification of therapy. Discussion: In many patients, the peri-procedural management of APT goes against current guidelines, but some of these inconsistencies cannot be considered true deviations from practice. Identified areas for improvement are increasing patient awareness about APT, disseminating the guidelines in Primary Care, and underscoring the significance of thrombotic risk related to APT withdrawal. (C) 2019 Elsevier Espana, S.L.U. All rights reserved. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|